Serum Homocysteine Relates to Elevated Lipid Level, Inflammation and Major Adverse Cardiac Event Risk in Acute Myocardial Infarction Patients

References

• Anderson JL , MorrowDA. Acute myocardial infarction. N. Engl. J. Med.376(21), 2053–2064 (2017).
   PubMed Web of Science ®Google Scholar
• Reed GW , RossiJE, CannonCP. Acute myocardial infarction. Lancet389(10065), 197–210 (2017).
   PubMed Web of Science ®Google Scholar
• GBD 2019 Diseases and Injuries Collaborators . Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet396(10258), 1204–1222 (2020).
   PubMed Web of Science ®Google Scholar
• Zhong Q , GaoY, ZhengXet al. Geographic variation in process and outcomes of care for patients with acute myocardial infarction in China From 2001 to 2015. JAMA Netw. Open3(10), e2021182 (2020).
   PubMedGoogle Scholar
• Reddy K , KhaliqA, HenningRJ. Recent advances in the diagnosis and treatment of acute myocardial infarction. World J. Cardiol.7(5), 243–276 (2015).
   PubMed Web of Science ®Google Scholar
• Harefa , WijayaIP, Muhadiet al. The association between 24-h blood pressure variability and major adverse cardiac events (MACE) in hospitalized patients with acute myocardial infarction: a retrospective cohort study. Egypt Heart J.73(1), 88 (2021).
   PubMedGoogle Scholar
• Wang YK , TangJN, HanLet al. Elevated FURIN levels in predicting mortality and cardiovascular events in patients with acute myocardial infarction. Metabolism111, doi:10.1016/j.metabol.2020.154323(2020) ( Online).
   Google Scholar
• Nair R , JohnsonM, KravitzKet al. Characteristics and outcomes of early recurrent myocardial infarction after acute myocardial infarction. J. Am. Heart Assoc.10(16), e019270 (2021).
   PubMed Web of Science ®Google Scholar
• Hermann A , SitdikovaG. Homocysteine: biochemistry, molecular biology and role in disease. Biomolecules11(5), 737 (2021).
   PubMedGoogle Scholar
• Han L , MiaoY, ZhaoYet al. The binding of autotaxin to integrins mediates hyperhomocysteinemia-potentiated platelet activation and thrombosis in mice and humans. Blood Adv.6(1), 46–61 (2022).
   PubMed Web of Science ®Google Scholar
• Tyagi N , SedorisKC, SteedMet al. Mechanisms of homocysteine-induced oxidative stress. Am. J. Physiol. Heart Circ. Physiol.289(6), H2649–H2656 (2005).
   PubMed Web of Science ®Google Scholar
• Zhang N , ShiF, LiangH, WangH. The feasibility of using Hcy, CRP, and Cys-C to analyze AMI patients' disease conditions and prognoses. Am. J. Transl. Res.13(4), 2724–2730 (2021).
   PubMed Web of Science ®Google Scholar
• Thygesen K , AlpertJS, JaffeASet al. Third universal definition of myocardial infarction. J. Am. Coll. Cardiol.60(16), 1581–1598 (2012).
   PubMed Web of Science ®Google Scholar
• Yun KH , RheeSJ, KoJS. Comparison of the infarct size between the loading of ticagrelor and clopidogrel in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Korean Circ. J.47(5), 705–713 (2017).
   PubMedGoogle Scholar
• Hong D , ChoiKH, SongYBet al. Prognostic implications of post-percutaneous coronary intervention neutrophil-to-lymphocyte ratio on infarct size and clinical outcomes in patients with acute myocardial infarction. Sci. Rep.9(1), 9646 (2019).
   PubMedGoogle Scholar
• Guan J , WuL, XiaoQ, PanL. Levels and clinical significance of serum homocysteine (Hcy), high-density lipoprotein cholesterol (HDL-C), vaspin, and visfatin in elderly patients with different types of coronary heart disease. Ann. Palliat. Med.10(5), 5679–5686 (2021).
   PubMedGoogle Scholar
• Duan H , ZhangQ, LiuJet al. Suppression of apoptosis in vascular endothelial cell, the promising way for natural medicines to treat atherosclerosis. Pharmacol. Res.168, doi:10.1016/j.phrs.2021.105599(2021) ( Online).
   PubMedGoogle Scholar
• Zhao J , ChenH, LiuNet al. Role of hyperhomocysteinemia and hyperuricemia in pathogenesis of atherosclerosis. J. Stroke Cerebrovasc. Dis.26(12), 2695–2699 (2017).
   PubMed Web of Science ®Google Scholar
• Grinan R , Escola-GilJC, JulveJ, BenitezS, RotllanN. Epigenetic regulation by microRNAs in hyperhomocysteinemia-accelerated atherosclerosis. Int. J. Mol. Sci.23(20), 12452 (2022).
   PubMed Web of Science ®Google Scholar
• Pang X , LiuJ, ZhaoJet al. Homocysteine induces the expression of C-reactive protein via NMDAr–ROS–MAPK–NF-κB signal pathway in rat vascular smooth muscle cells. Atherosclerosis236(1), 73–81 (2014).
   PubMed Web of Science ®Google Scholar
• Sharma M , RaiSK, TiwariM, ChandraR. Effect of hyperhomocysteinemia on cardiovascular risk factors and initiation of atherosclerosis in Wistar rats. Eur. J. Pharmacol.574(1), 49–60 (2007).
   PubMedGoogle Scholar
• Viles-Gonzalez JF , FusterV, BadimonJJ. Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur. Heart J.25(14), 1197–1207 (2004).
   PubMed Web of Science ®Google Scholar
• Daly C , FitzgeraldAP, O'CallaghanPet al. Homocysteine increases the risk associated with hyperlipidaemia. Eur. J. Cardiovasc. Prev. Rehabil.16(2), 150–155 (2009).
   PubMedGoogle Scholar
• Liu C , YangY, PengD, ChenL, LuoJ. Hyperhomocysteinemia as a metabolic disorder parameter is independently associated with the severity of coronary heart disease. Saudi Med. J.36(7), 839–846 (2015).
   PubMedGoogle Scholar
• Werstuck GH , LentzSR, DayalSet al. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J. Clin. Invest.107(10), 1263–1273 (2001).
   PubMed Web of Science ®Google Scholar
• Li JJ , LiQ, DuHPet al. Homocysteine triggers inflammatory responses in macrophages through inhibiting CSE-H2S signaling via DNA hypermethylation of CSE promoter. Int. J. Mol. Sci.16(6), 12560–12577 (2015).
   PubMedGoogle Scholar
• Ireland SJ , MonsonNL, DavisLS. Seeking balance: potentiation and inhibition of multiple sclerosis autoimmune responses by IL-6 and IL-10. Cytokine73(2), 236–244 (2015).
   PubMedGoogle Scholar
• Guieu R , RufJ, MottolaG. Hyperhomocysteinemia and cardiovascular diseases. Ann. Biol. Clin. (Paris)80(1), 7–14 (2022).
   PubMed Web of Science ®Google Scholar
• Basalay MV , YellonDM, DavidsonSM. Targeting myocardial ischaemic injury in the absence of reperfusion. Basic Res. Cardiol.115(6), 63 (2020).
   PubMedGoogle Scholar
• Lai XL , LiuHX, HuXet al. Acute myocardial infarction in Chinese medicine hospitals in China from 2006 to 2013: an analysis of 2311 patients from hospital data. Chin. J. Integr. Med.27(5), 323–329 (2021).
   PubMedGoogle Scholar
• Song J , MurugiahK, HuSet al. Incidence, predictors, and prognostic impact of recurrent acute myocardial infarction in China. Heart107(4), 313–318 (2020).
   PubMedGoogle Scholar
• Yan J , ZhouJ, HuangJet al. The outcomes of acute myocardial infarction patients comorbidity with hypertension and hyperhomocysteinemia. Sci. Rep.11(1), 22936 (2021).
   PubMedGoogle Scholar
• Fu Z , YangX, ShenMet al. Prognostic ability of cystatin C and homocysteine plasma levels for long-term outcomes in very old acute myocardial infarction patients. Clin. Interv. Aging.13, 1201–1209 (2018).
   PubMed Web of Science ®Google Scholar
• Moretti R , CarusoP. The controversial role of homocysteine in neurology: from labs to clinical practice. Int. J. Mol. Sci.20(1), 231 (2019).
   PubMed Web of Science ®Google Scholar
• Bhatt DL , LopesRD, HarringtonRA. Diagnosis and treatment of acute coronary syndromes: a review. JAMA327(7), 662–675 (2022).
   PubMed Web of Science ®Google Scholar
• Merry AH , BoerJM, SchoutenLJet al. Smoking, alcohol consumption, physical activity, and family history and the risks of acute myocardial infarction and unstable angina pectoris: a prospective cohort study. BMC Cardiovasc. Disord.11, 1–14 (2011).
   PubMedGoogle Scholar
• Maddox TM , ReidKJ, RumsfeldJS, SpertusJA. One-year health status outcomes of unstable angina versus myocardial infarction: a prospective, observational cohort study of ACS survivors. BMC Cardiovasc. Disord.7, 28 (2007).
   PubMedGoogle Scholar